KMG Fiduciary Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $266K | Hold |
2,478
| – | – | 0.02% | 264 |
|
2025
Q1 | $250K | Sell |
2,478
-132
| -5% | -$13.3K | 0.02% | 260 |
|
2024
Q4 | $233K | Sell |
2,610
-122
| -4% | -$10.9K | 0.02% | 260 |
|
2024
Q3 | $229K | Buy |
2,732
+50
| +2% | +$4.19K | 0.02% | 255 |
|
2024
Q2 | $207K | Buy |
+2,682
| New | +$207K | 0.02% | 237 |
|
2021
Q4 | – | Sell |
-8,156
| Closed | -$354K | – | 200 |
|
2021
Q3 | $354K | Buy |
8,156
+327
| +4% | +$14.2K | 0.06% | 156 |
|
2021
Q2 | $335K | Sell |
7,829
-650
| -8% | -$27.8K | 0.06% | 155 |
|
2021
Q1 | $328K | Sell |
8,479
-34,227
| -80% | -$1.32M | 0.06% | 143 |
|
2020
Q4 | $1.55M | Buy |
42,706
+7,810
| +22% | +$283K | 0.33% | 70 |
|
2020
Q3 | $1.33M | Buy |
34,896
+134
| +0.4% | +$5.12K | 0.33% | 67 |
|
2020
Q2 | $1.22M | Sell |
34,762
-2,197
| -6% | -$77.1K | 0.34% | 67 |
|
2020
Q1 | $1.21M | Buy |
36,959
+14,870
| +67% | +$485K | 0.39% | 61 |
|
2019
Q4 | $999K | Buy |
+22,089
| New | +$999K | 0.3% | 57 |
|